Center of Constitutional Transitions’ director and founder Choudhry is recognized internationally as a scholar and constitutional lawyer. Choudhry has given advice in several countries including Kenya, Nigeria, Sri Lanka, the Ukraine and Cyprus through the decades on governance, and constitution building. He offered a companion to the policy paper co-authored by George Anderson to clarify “Territory and Power in Constitutional Transitions.”
The original paper covered case studies from countries involved with constitutional engagement. The essay collection gives recommendations for policy based on realistic views of political and territorial cleavages. There is a chapter that uses a comparative analysis of case studies relating them to current research for drawing original conclusions.
Anderson’s back ground is in the Canadian government and he was formerly the Forum of Federations’ CEO. The companion paper had the same title as the original to give insight into the things discussed in the original. The advice in the paper might be helpful to those who advice and are principal in the constitutional moments.
Sujit Choudhry became a Solicitor and Barrister during 2001 in Ontario, Canada. Choudhry has spoken or given lectures in 30 countries and worked in vast contexts such as political violence and cease fires. He has experience in facilitating sessions of public dialogue with stakeholders and civil society groups, multi-party dialogue technical advice and various other consultations and technical experts advisory work. He has over 100 articles, policy manuals, book chapters, working papers and reports. Sujit Choudhry is also an expert on the constitution of Canada.
Read more here https://sujitchoudhry.com/news-coverage/
EUSA Pharma is a pharmaceutical company that specializes in creating and developing critical care, pain control, and oncology products. Xenazine, Vectibix, Fomepizole, and Prolia are only to mention a few of the pharmaceutical company’s products. Offering products globally, EUSA Pharma Europe is headquartered in Hemel Hempstead, United Kingdom.
Carsten Thiel currently serves as EUSA Pharma Europe’s President. In an article dated March 7th of 2019, we take a closer look at the President of the pharmaceutical company. The article begins to introduce Carsten Thiel and names some of the products that EUSA Pharma currently offers. It then begins to describe Mr. Thiel’s background. In it, it states that he is a native of Berlin, Germany. He later studied in the town of Marburg, where he took classes in chemistry. The article continues to account for Mr. Thiel’s educational background. Notably, the article mentions that he earned his Doctor of Philosophy degree in Molecular Biology at the Max Planck Institute for Biophysical Chemistry.
After academic life, Mr. Thiel’s career began at the biotech firm, Hoffman La-Roche. Through his experience at the firm, Mr. Thiel gained additional knowledge in the field of biochemistry. The article then briefly discusses some of the roles he formerly held at the firm.
Next, the article discusses the drug called Xenical and the role Mr. Thiel played in its success. Xenical is a drug designed to treat obesity. It is taken in conjunction with exercise, a reduced-calorie diet, and behavior change prescribed by a physician. Through his expertise, Mr. Thiel created a successful strategy in marketing the product. The article indicates that his approach to marketing Xenical was unique. In it, it states that he opted to go for a “slow and steady” approach rather than an aggressive “sudden surge” strategy that many specialty pharmaceutical companies utilize when launching a new product. The article continues to narrate Mr. Thiel’s career, achievements, and leadership skills.
For details: prabook.com/web/carsten.thiel/3754190
Richard Liu Qiangdong embarked on an entrepreneurial journey in 1998. He started a restaurant but the business failed for lack of good management. At the time, he was juggling between studies and business. It became difficult for him to focus on studies while running the business and consequently, it closed down. He narrates how he became the owner of JD.COM, the largest e-commerce platform in China, and one of China’s richest individuals with a net worth of about $11 billion at the World Economic Forum Annual Meeting last year.
Richard Liu Qiangdong revealed at his family was facing financial problems when he decided to give it a try again in business. He could have wanted to go abroad and pursue higher studies but he couldn’t because of the financial challenges. He started a computer business in Beijing. The business grew rapidly to expand into twelve brick-and-mortar locations. However, the SARS epidemic forced the entrepreneur to close down the businesses. He transitioned into e-commerce swiftly leveraging tech skills he had taught himself.
He launched JD.COM officially in 2004 and started providing IT equipment, digital electronics and mobile phones online. Today, the platform is valued at about $57 billion. Richard Liu is the CEO and the owner of the company and the company’s directors cannot form a quorum without him. Today, the platform boasts more than one billion products, making it a go-to shopping platform which enables shoppers to buy everything they need ‘under one roof’. The company has managed to stay ahead of competition because of its fast-delivery system and a wide variety of products. If you order a product from Jingdong at Beijing, the product will be delivered to you within three hours. It takes up to six hours to deliver products to customers in the rest of the world.
Richard Liu was raised in a hardworking family who taught him how to be self-reliant. Growing up, he had friends who studied with him and it turns out, they are all successful today. According to the e-commerce entrepreneur, they were all a hard working lot. Richard Liu Qiangdong values his family so much that he considers his greatest achievement.
To know more click: here.
HGGC is a reputable privately held venture capital and private equity firm with headquarters based in Palo Alto, California. The firm was founded in 2007 by Steve Young, Bob Gay, Richard Lawson, and Gregory Benson. Since its inception, the firm has completed add-on acquisitions, platform investments, liquidity events, and recapitalizations with an aggregate transaction value of over $19 billion. Currently, the company has over $4.3 billion in cumulative capital commitments. The company has over 166 portfolio investments and employs more than 62 000 employees on a global scale. HGGC boasts one of the largest investors across their funds investing $300 million and a $1.6 billion seller roll over reinvestment.
Focusing on middle market company makes HGGC stand out among the private equity firms. The firm invests in high potential middle market companies which they believe they have a competitive position in the market. HGGC adds value to the prospective middle market firms to enable the firms to outperform the competition-intensive market. Besides, the firm utilizes a great partnership model with a relationship investing that drives equity and mutual benefit among all participants. The firm uses an advantaged investing models seeking to leverage on their skillset to develop strong multi-sector networks to build relationships and multi-sector networks that leads to alignment of interests and enhanced networks.
HGGC primarily focuses on investments in North America but also considers prospective companies beyond. The firm seeks to invest in business services, manufacturing, software, technology, chemicals, industrial facilities, financial services, and consumer products. The firm spends typically $25 – $125 million in companies with annual revenue of $100-$1000 million. The firm seeks to take either majority or minority positions in all partner companies but with control rights. The company’s management team has continually proved to possess excellent skills in selecting potentially growing mid-market companies. The team has decades of collective operational and deal experience with a unique talent that has helped the firm transform middle market businesses into business giants. Some of the best-performing companies in their portfolio include; RPX, AutoAlert, Mi9, Helpsystems, Denodo, Serena, IDERA, Aventri, Sunquest, Power Holdings, Hollander, and Neutraceutical to highlight just a few.